REBECCA HARTZOG: Open Payments
NPI 1215267018 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,165 in 152 payments from 16 companies in 2025. Trend: 2023 $2,895 · 2024 $6,890 · 2025 $6,165
Speaker / faculty: $3,375Food & beverage: $2,758Travel & lodging: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $3,886 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $441 |
| Axsome Therapeutics, Inc. | 19 | $337 |
| Teva Pharmaceuticals USA, Inc. | 8 | $212 |
| Collegium Pharmaceutical, Inc. | 12 | $193 |
| Vanda Pharmaceuticals Inc. | 11 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. | 5 | $147 |
| Janssen Pharmaceuticals, Inc | 12 | $140 |
| Supernus Pharmaceuticals, Inc. | 6 | $131 |
Products named: VRAYLAR, CAPLYTA, Auvelity, REXULTI, AUSTEDO XR, Jornay PM, FANAPT, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
